HomeAI · summaries
Storia in 6 fonti
Takeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful
After coming up short in trials with two orexin type 2 receptor (OX2R) selective agonists, Takeda has scored with oveporexton,
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
The FDA approved a novel type of treatment for narcolepsy made by Takeda, backing a new drug class that scientists hope can be used to treat other conditions.
- ·
endpoints.news
Let the orexin market begin: Takeda snags FDA approval for narcolepsy type 1 drug
Takeda's Orzeyful wins FDA approval as the first full-symptom narcolepsy type 1 drug, kicking off an orexin agonist race with Lilly and Alkermes close behind.
